FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma

Submitted by admin on February 16, 2024 - 11:42am

Source:

Medical Marketing and Media

News Tags:

CAR-T

FDA

Peter Marks

CBER

Headline:

FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma

snippet:

The release of added context on the benefit-risk profile of CAR-T therapies underscores how safety is moving from the periphery into the category’s forefront.

Search form

You are here

FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma

FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma